Matches in Nanopublications for { ?s ?p "[Loss of Tuberous Sclerosis Complex 2 (TSC2) Is Frequent in Hepatocellular Carcinoma and Predicts Response to mTORC1 Inhibitor Everolimus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[Loss of Tuberous Sclerosis Complex 2 (TSC2) Is Frequent in Hepatocellular Carcinoma and Predicts Response to mTORC1 Inhibitor Everolimus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Loss of Tuberous Sclerosis Complex 2 (TSC2) Is Frequent in Hepatocellular Carcinoma and Predicts Response to mTORC1 Inhibitor Everolimus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1266909.RAnQkUdmHwbePu3zTi2Efg5gcC7szyYGT_6DumjKkunkw130_assertion description "[Loss of Tuberous Sclerosis Complex 2 (TSC2) Is Frequent in Hepatocellular Carcinoma and Predicts Response to mTORC1 Inhibitor Everolimus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266909.RAnQkUdmHwbePu3zTi2Efg5gcC7szyYGT_6DumjKkunkw130_provenance.
- NP1266912.RAFP40CE3FVrznkqkSXT0L4HV8T32Lm94-eG-Q__kqiac130_assertion description "[Loss of Tuberous Sclerosis Complex 2 (TSC2) Is Frequent in Hepatocellular Carcinoma and Predicts Response to mTORC1 Inhibitor Everolimus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266912.RAFP40CE3FVrznkqkSXT0L4HV8T32Lm94-eG-Q__kqiac130_provenance.